DuChemBio announced Friday it will invest 33.56 billion won ($24.7 million) in a new facility.
The investment represents 68.2 percent of the company's equity capital and will run from Sept. 7 through Dec. 31, 2032.
The company said the funds are intended to build a contract development and manufacturing organization factory and research and development center specializing in radiopharmaceutical therapeutics.
jiyoon436@heraldcorp.com
